Costa, Monica Barros <br/><br/>
Aldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome.  [electronic resource] 

 -  Journal of clinical hypertension (Greenwich, Conn.)  Sep 2010 
 - 753-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter 
<br/><br/><label>ISSN: </label>1751-7176 
<br/><br/><label>Standard No.: </label>10.1111/j.1751-7176.2010.00339.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Pressure--drug effects<br/>Female<br/>Humans<br/>Hypertension--complications<br/>Male<br/>Metabolic Syndrome--drug therapy<br/>Middle Aged<br/>Mineralocorticoid Receptor Antagonists--pharmacology<br/>Obesity--complications<br/>Spironolactone--pharmacology<br/>Treatment Outcome